Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG: 0874)
Hong Kong
· Delayed Price · Currency is HKD 17.46
-0.26 (-1.47%)
Sep 9, 2024, 3:22 PM HKT
Guangzhou Baiyunshan Pharmaceutical Holdings Company Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | - | 4,056 | 3,967 | 3,720 | 2,915 | 3,189 | Upgrade
|
| Depreciation & Amortization | - | 875.36 | 743.83 | 676.99 | 644.2 | 591.89 | Upgrade
|
| Other Amortization | - | 109.96 | 49.83 | 43.53 | 35.35 | 33.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -12.03 | -0.69 | -0.69 | -2.95 | -1.27 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | -0.42 | 7.06 | 3.08 | 2.89 | 2.41 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -288.71 | -417.58 | -390.47 | -335.7 | -230.08 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 73.53 | 54.55 | 95.1 | 100.12 | 103.42 | Upgrade
|
| Other Operating Activities | - | 660.47 | 715.79 | 659.84 | 544.5 | 640.8 | Upgrade
|
| Change in Accounts Receivable | - | -417.27 | -1,992 | -1,627 | -572.17 | -1,868 | Upgrade
|
| Change in Inventory | - | -835.03 | -242.22 | -673.65 | -265.44 | -221.36 | Upgrade
|
| Change in Accounts Payable | - | -66.12 | 4,121 | 3,158 | -2,351 | 2,791 | Upgrade
|
| Operating Cash Flow | - | 4,104 | 6,999 | 5,673 | 585.19 | 5,022 | Upgrade
|
| Operating Cash Flow Growth | - | -41.37% | 23.36% | 869.52% | -88.35% | -3.73% | Upgrade
|
| Capital Expenditures | - | -1,628 | -1,384 | -1,255 | -876.5 | -2,400 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 13.93 | 1.49 | 6.61 | 6.15 | 1.12 | Upgrade
|
| Cash Acquisitions | - | - | 147.67 | -1.39 | - | -2.22 | Upgrade
|
| Divestitures | - | - | - | 32.57 | -34.75 | - | Upgrade
|
| Investment in Securities | - | -1,885 | -6,233 | 42.79 | -509.38 | 1,232 | Upgrade
|
| Other Investing Activities | - | 384.46 | 214.82 | 242.77 | 326.42 | 140.84 | Upgrade
|
| Investing Cash Flow | - | -3,115 | -7,253 | -931.57 | -1,088 | -1,028 | Upgrade
|
| Short-Term Debt Issued | - | 299.96 | 599.91 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 9,604 | 9,696 | 8,826 | 8,918 | 7,119 | Upgrade
|
| Total Debt Issued | - | 9,904 | 10,296 | 8,826 | 8,918 | 7,119 | Upgrade
|
| Short-Term Debt Repaid | - | -900 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -9,646 | -8,422 | -8,943 | -6,159 | -7,952 | Upgrade
|
| Total Debt Repaid | - | -10,546 | -8,422 | -8,943 | -6,159 | -7,952 | Upgrade
|
| Net Debt Issued (Repaid) | - | -642.15 | 1,874 | -116.76 | 2,759 | -832.74 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 0 | Upgrade
|
| Common Dividends Paid | - | -1,585 | -1,491 | -1,266 | -1,290 | -1,046 | Upgrade
|
| Other Financing Activities | - | 249.35 | -337.16 | -111.17 | -29.95 | -353.38 | Upgrade
|
| Financing Cash Flow | - | -1,978 | 45.95 | -1,494 | 1,439 | -2,232 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 8.08 | -0.5 | 0.28 | -4.99 | -0.15 | Upgrade
|
| Net Cash Flow | - | -981.16 | -208.67 | 3,248 | 931.51 | 1,762 | Upgrade
|
| Free Cash Flow | - | 2,475 | 5,615 | 4,419 | -291.32 | 2,623 | Upgrade
|
| Free Cash Flow Growth | - | -55.92% | 27.08% | - | - | -44.65% | Upgrade
|
| Free Cash Flow Margin | - | 3.28% | 7.93% | 6.40% | -0.47% | 4.04% | Upgrade
|
| Free Cash Flow Per Share | - | 1.52 | 3.45 | 2.72 | -0.18 | 1.61 | Upgrade
|
| Cash Income Tax Paid | - | 3,140 | 2,759 | 2,873 | 2,638 | 2,999 | Upgrade
|
| Levered Free Cash Flow | - | 1,016 | 3,947 | 1,963 | -1,471 | 318.86 | Upgrade
|
| Unlevered Free Cash Flow | - | 1,295 | 4,219 | 2,224 | -1,244 | 564.89 | Upgrade
|
| Change in Net Working Capital | 2,981 | 906.44 | -2,005 | -277.34 | 2,938 | -138.78 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.